Positive results reported thus far concerning Aflibercept (VEGF Trap)
More will probably be reported on this
and
here's an interesting thought:
"Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis"
at:pnas.org/content/108/26/10668
Comments
-
live links
http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=1859
Aflibercept significantly improves survival
http://www.pnas.org/content/108/26/10668
Circadian clock disruption
Okay, here's live links but these articles aren't thrilling me with interest...the Aflibercet trial results showed: "The addition of aflibercept to the FOLFIRI regimen significantly improved both overall survival (13.5 months median overall survival vs. 12.06 months in the control arm; HR=0.817; p=0.0032) and progression-free survival (6.9 months median progression-free survival vs. 4.67 months in the control arm" ...one month or so? significant, really?
The second article's abstract would be hard for some to understand...if I'm getting it right, it relates to tumors that have a mutant gene being affected negatively by circadian disruption.
Thanks again for the research you share here, though I'm not interested in every piece I can't tell you how much I appreciate every single time you put up some new info!
Janine0 -
How many months?SisterSledge said:live links
http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=1859
Aflibercept significantly improves survival
http://www.pnas.org/content/108/26/10668
Circadian clock disruption
Okay, here's live links but these articles aren't thrilling me with interest...the Aflibercet trial results showed: "The addition of aflibercept to the FOLFIRI regimen significantly improved both overall survival (13.5 months median overall survival vs. 12.06 months in the control arm; HR=0.817; p=0.0032) and progression-free survival (6.9 months median progression-free survival vs. 4.67 months in the control arm" ...one month or so? significant, really?
The second article's abstract would be hard for some to understand...if I'm getting it right, it relates to tumors that have a mutant gene being affected negatively by circadian disruption.
Thanks again for the research you share here, though I'm not interested in every piece I can't tell you how much I appreciate every single time you put up some new info!
Janine
I started Avastin in March of 2004, shortly after my dx and when it first became approved by the FDA. I was part of an AP story on the high cost of drugs and whether they are worth it or not. The claim with Avastin was that is would give the sickest cancer patients about 5 more months to live.
That was 7 years ago.
I'm thankful for Avastin and Erbitux, both are part of the new-ish targeted therapies for treating cancer with the hope of doing less collateral damage (ugh! that word...collateral) to healthy cells that traditional chemotherapy but the abstracts that they provide always seem so glum to me. Five months more than those who brush with Crest TM?
It's good to see that they are trying something but the more I see, the more I see it's mainly medicine that get all funding and then once they approve the medications, many people can't afford it. The Erbitux was $17,000 a month back in 2005. Everything is profit-driven.
OK, I'm getting side-tracked...too many fireworks!
I echo Janine, thanks for keeping us informed people Steve
-p0 -
Here'a a little article about some of Dr Lenz's research:PhillieG said:How many months?
I started Avastin in March of 2004, shortly after my dx and when it first became approved by the FDA. I was part of an AP story on the high cost of drugs and whether they are worth it or not. The claim with Avastin was that is would give the sickest cancer patients about 5 more months to live.
That was 7 years ago.
I'm thankful for Avastin and Erbitux, both are part of the new-ish targeted therapies for treating cancer with the hope of doing less collateral damage (ugh! that word...collateral) to healthy cells that traditional chemotherapy but the abstracts that they provide always seem so glum to me. Five months more than those who brush with Crest TM?
It's good to see that they are trying something but the more I see, the more I see it's mainly medicine that get all funding and then once they approve the medications, many people can't afford it. The Erbitux was $17,000 a month back in 2005. Everything is profit-driven.
OK, I'm getting side-tracked...too many fireworks!
I echo Janine, thanks for keeping us informed people Steve
-p
eurekalert.org/pub_releases/2011-07/uosc-url070511.php "USC researchers link genetic marker to rectal cancer treatment."......ieSurgery and Erbitux
nanowerk.com/newsid=21981.php on nano and cancer0 -
LynxcoloCan said:Here'a a little article about some of Dr Lenz's research:
eurekalert.org/pub_releases/2011-07/uosc-url070511.php "USC researchers link genetic marker to rectal cancer treatment."......ieSurgery and Erbitux
nanowerk.com/newsid=21981.php on nano and cancer
or links...
USC researchers link genetic marker to rectal cancer treatment."
Second link didn't see to be active Steve.
-p0 -
Of course it didn't work, i mistyped it........left out part ofPhillieG said:Lynx
or links...
USC researchers link genetic marker to rectal cancer treatment."
Second link didn't see to be active Steve.
-p
the address....At least one of us can still think strait (direly)......0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 396 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 538 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards